Authors
Latest:
No consensus: Clinical trials wrestle with role of atropine in treating amblyopiaBaltimore-Amblyopia is a relatively common problem in children, but there is no consensus on the best treatment. Recently, there has been increasing interest in using atropine drops instead of patching, but they are not FDA approved for that indication, said Michael X. Repka, MD.
Latest:
Patients taking digoxin may develop color blindnessLondon-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Latest:
Double concentration of olopatadine controls allergies all dayWailea, HI-Olopatadine 0.2% (Patanol, Alcon) significantly reduced itching and redness for 24 hours, according to the results of a study presented at the annual meeting of the Western Society of Allergy, Asthma & Immunology.
Latest:
Allergy agent more potent in inhibition of IL-6, tryptaseBoston-Ophthalmic solutions of azelastine HCl (Optivar, Asta Medica/Muro Pharmaceutical Inc., Tewksbury, MA) and olopatadine HCl (Patanol, Alcon Laboratories, Fort Worth, TX) both effectively inhibit the activation of normal cultured human mast cells and the release of interleukin-6 (IL-6), tryptase, and histamine. However, azelastine seemed to be substantially more potent for treating ocular allergy when the two drugs were compared in an in vitro study.
Latest:
Inflammatory glaucoma is a management challengeChicago-The diagnosis and treatment of inflammatory glaucoma remain one of the most challenging problems for ophthalmologists, according to Chicago glaucoma specialist Jon M. Ruderman, MD.
Latest:
New guidelines focus on medical management of glaucomaMaui, HI-Evidence-based guidelines for the medical management of glaucoma developed by a panel of glaucoma specialists aim to enhance clinical decision-making for the general ophthalmologist, said Anne L. Coleman, MD, PhD, at the annual Royal Hawaiian Eye meeting here.
Latest:
Hyperhomocysteinemia may be risk factor for exfoliation syndromeS?o Paulo, Brazil-Hyperhomocysteinemia appears to be associated with exfoliation syndrome and might be a modifiable risk factor for that disorder, said Roberto M. Vessani, MD, who was a glaucoma fellow with Glaucoma Associates of New York and is currently glaucoma preceptor, glaucoma service, department of ophthalmology, University of S?o Paulo, Brazil.
Latest:
Gatifloxacin approvedCA-The FDA approval of gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) marks a milestone as the first fourth-generation fluoroquinolone to enter the ophthalmic market. The therapy for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria also has a unique mechanism to prevent development of antibiotic resistance, according to Allergan.
Latest:
APAO 2023: Beveled tip probe an all-in-one instrument for retinal detachment vitrectomyYusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
Latest:
IPL + thermal pulsation: A thorough approach to dry eyeIPL + thermal pulsation: A thorough approach to dry eye
Latest:
Old friends and good wineLike many of us, Vance Thompson, MD, loves wine. For Dr. Thompson, director of refractive surgery for Sioux Valley Clinic in Sioux Falls, SD, vacations to California's Napa Valley led to a business opportunity that teaches him much about wine, people, and business.
Latest:
Single-use microkeratome results similar to reusable bladeS?o Paulo-A comparative study has demonstrated that the M2 130 Single-Use microkeratome (Moria, Antony, France) performs identically to its reusable counterpart, the conventional M2 110. In addition, the Single-Use microkeratome is significantly easier to use and allows greater visibility, according to Renato A. Neves, MD, director of Eye Care Oftalmologia LASER Vision Centers here.
Latest:
Tonometer challenges standard with corneal hysteresisUse of drugs and drainage implants also improves trabeculectomy outcomes
Latest:
Software upgrade advances torsional ultrasoundA phacoemulsification software upgrade further enhances safety, efficiency, and control for surgeons performing torsional ultrasound with proprietary handpiece and phaco system.
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
Joey Gase named ambassador by National Keratoconus FoundationThe National Keratoconus Foundation has named NASCAR driver Joey Gase as Ambassador.
Latest:
Lambda technique offers surgeons safe, rapid phaco methodAlmost all current phacoemulsification techniques involve both the breaking up of the nucleus into pieces and phacoemulsification. The mainstream techniques in current implementation are the divide-and-conquer method and the chopping techniques. The Lambda technique is an innovative implementation of the divide-and-conquer technique.
Latest:
Prescription services added to Medicare coverageWashington, DC-The addition of insurance coverage for prescription drugs in the Medicare Prescription Drug and Modernization Act signed by President Bush is being called an historic victory for seniors.
Latest:
Ocular allergy control possible with once-daily dosingNiagara Falls, Ontario-Switching to once-daily instillation of nedocromil sodium 2% ophthalmic solution (Alocril, Allergan) is an effective alternative for maintaining control of ocular symptoms of seasonal allergic conjunctivitis after acute relief is obtained with twice-daily administration, according to an environmental study conducted by Michael Alexander, MD.
Latest:
HLA-B27-associated anterior uveitis a common presentationEditor's Note: Anterior uveitis is the most common type of intraocular inflammation. Among patients with inflammation localized primarily to the anterior chamber, 50% or more are HLA-B27 positive. Inaddition, a number of these patients with HLA-B27-associated anterior uveitis have, or will develop, an associated systemicdisorder such as ankylosing spondylitis,reactive arthritis (formerly known asReiter's syndrome), inflammatory bowel disease, or psoriatic arthritis.
Latest:
Innovation Series: A stem cell patch for treating advanced dry AMDIn this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, about the progress made by a team of USC researchers on a novel stem cell patch for treating advanced dry age-related macular degeneration.
Latest:
Double concentration of olopatadine controls allergies all dayWailea, HI-Olopatadine 0.2% (Patanol, Alcon) significantly reduced itching and redness for 24 hours, according to the results of a study presented at the annual meeting of the Western Society of Allergy, Asthma & Immunology.
Latest:
Easy ways to create eye-catching displaysVisual merchandising is the art of displaying merchandise to encourage sales. Dispensing ophthalmology practices can create eye-catching displays by following some simple rules. Grouping frames by price point and brand helps to organize options for the customer. Displays can highlight individual brands through repetition, a pyramid design, using odd, rather than even numbers of items, considering the texture of background materials, and more.
Latest:
Poor corporate governance makes business headlinesBusiness publications have been dominated recently by stories of corporate tricks, distortions, falsehoods, and a wide variety of other malfeasance. Corporate governance is thus receiving attention like never before. It has been a topic of major concern at the executive, legislative, and judicial branches of government as well as in society at large.
Latest:
Unique model illustrates fluidic flow during torsional phacoCharleston, SC-Torsional phacoemulsification, which is accomplished with the OZil handpiece (Alcon Laboratories), is the newest incarnation of a phacoemulsification process that has remained virtually unchanged for 4 decades, since Charles Kelman, MD, introduced ultrasonic phacoemulsification. The improvements promised by this torsional technology include less dispersion of nuclear fragments, improved cutting performance, and improved thermal safety profile.
Latest:
Corticosteroid shown to be safe for long-term SAC controlTampa, FL-Loteprednol etabonate ophthalmic suspension 0.2% (Alrex, Bausch & Lomb Pharmaceuticals and Pharmos Corp.), the first corticosteroid specifically designed for signs and symptoms of seasonal allergic conjunctivitis (SAC), is safe for long-term use, according to a recent multicenter study.
Latest:
Facial anatomy key to optimal use of botulinum toxinBotulinum toxin type A effect is usually seen 2 to 3 days following injection, with maximal effect at approximately 2 weeks. Touch-ups are not recommended until 2 weeks have passed.
Latest:
Exposures of porous orbital implants can be avoidedIn the past decade, porous orbital implants have become the implant of choice for many surgeons managing the anophthalmic socket after enucleation or evisceration. By permitting fibrovascular ingrowth, these porous implants are better able to resist infection, migration, and extrusion when compared with acrylic or silicone implants.
Latest:
GA therapy demonstrates continuous, sustained effects of pegcetacoplan over timePhysician offers "real talk" on pros and cons that offers surgeons and patients decision-making insights.
